Blood stem cell mutations quietly drive aging

As people age, their blood-forming stem cells (hematopoietic stem cells) accumulate mutations. Occasionally, a mutation gives one cell a competitive edge. That cell divides more frequently and gradually crowds out others. When more than two percent of circulating blood cells descend from a single mutated clone, researchers refer to this as clonal hematopoiesis of indeterminate potential, or CHIP.

CHIP is not cancer, but it is not harmless either. The researchers describe how CHIP is associated with an increased risk of cardiovascular and neurological conditions. The proposed mechanism involves pro-inflammatory signaling: mutated immune cells appear to sustain low-grade chronic inflammation, known as inflammaging, throughout the body, which is a recognized driver of multiple age-related diseases.

Bone marrow as a focal point

Bone marrow does more than produce blood cells. It is also the environment in which stem cells decide whether to divide or remain dormant. As the marrow changes with age, mutated clones gain further advantage. The most commonly mutated genes in CHIP include DNMT3A, TET2, and ASXL1, all of which regulate gene activity. Errors in these genes alter not just blood cell production but also how immune cells respond to infection and tissue damage.

Risk factor or cause?

The authors stress an important caveat: evidence in humans is largely epidemiological. CHIP correlates with faster biological aging and higher disease risk, but whether it is a direct cause or a marker of underlying cellular damage has not been definitively resolved. That distinction matters enormously for whether treating CHIP early would actually reduce harm.

Diagnostic tools are becoming more sensitive, and researchers are beginning to explore ways to slow clonal expansion or limit its downstream effects. From a longevity perspective, this is worth watching: if CHIP genuinely accelerates aging, the bone marrow could become a target for early intervention.

Read the original article